Dual-antibody drug

Recent Articles

RELATED ARTICLES

  1. Shares in this Chinese pharmaceutical company swung back and forth as investors tried to make sense of clinical trial data for an immunotherapy drug billed as a potential world beater.
    Test results for new cancer drug take Akeso investors on wild ride
    9926.HK
  2. Akeso marks profit milestone with swift rights issue
    9926.HK
  3. Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
    1952.HK
  4. Facing revenue crisis, Ascletis Pharma tries to bulk up with obesity drugs
    1672.HK
  5. Clinical trials come up short again for Alphamab Oncology
    9966.HK
  6. Junshi hopes new scientist CEO can cure its woes
    1877.HK 688180.SHG
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva